Microbio

4128.TWO

0.47 USD

-0.01

-2.08%

Overview

Last close

0.47 usd

Market cap

276.99M usd

52 week high

1.26 usd

52 week low

0.47 usd

Target price

N/A usd

Valuation

P/E

N/A

Forward P/E

1111.1111

Price/Sales

4.6113

Price/Book Value

0.9898

Enterprise Value

217.02M usd

EV/Revenue

3.6126

EV/EBITDA

-10.9139

Key financials

Revenue TTM

60.07M usd

Gross Profit TTM

23.90M usd

EBITDA TTM

-9.84M usd

Earnings per Share

-0.04 usd

Dividend

N/A usd

Total assets

392.93M usd

Net debt

N/A usd

About

Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. The company provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia in women before menopause and relieved dysmenorrhea. It also involved in the trading of organic foods; sale of beverages; provision of technology development, transfer, and consultation services; and publishing of magazine, as well as offers business consulting services. Microbio Co., Ltd. was incorporated in 2000 and is based in Taipei, Taiwan.